Skip to main content
Midas Edge

ELUTIA INC

For the period ended Mar 31, 2024. Filed May 13, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 13, 2024

ELUT$0.84-0.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 6. Exhibits

ExhibitNumber · Description · Form · File No. · Exhibit · Filing Date · Filed/ Furnished Herewith
​​​​​​​​
10.1​Amendment No. 1 to Royalty Agreement with Ligand Pharmaceuticals Incorporated8-K001-3957710.11/12/2024​
​​​​​​​​
10.2​Form of Amendment to Stock Option Agreements, dated January 31, 2024, between the Company and C. Randal Mills, Ph.D.8-K001-3957710.12/2/2024†
​​​​​​​​
10.3​Form of Amendment to Restricted Stock Unit Agreements, dated January 31, 2024, between the Company and C. Randal Mills, Ph.D.8-K001-3957710.22/2/2024†
​​​​​​​​
10.4​Form of Stock Option Agreement under the Elutia Inc. Amended and Restated 2020 Incentive Award Plan.8-K001-3957710.32/2/2024†
​​​​​​​​
10.5​Form of Restricted Stock Unit Agreement under the Elutia Inc. Amended and Restated 2020 Incentive Award Plan.8-K001-3957710.42/2/2024†
​​​​​​​​
31.1​Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
​
31.2​Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
​
32.1​Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
​
32.2​Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
​
101.INS​Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.*
​
101.SCH​Inline XBRL Taxonomy Extension Schema Document*
​
101.CAL​Inline XBRL Taxonomy Extension Calculation Linkbase Document*
​
101.DEF​Inline XBRL Taxonomy Extension Definition Linkbase Document*
​
101.LAB​Inline XBRL Taxonomy Extension Label Linkbase Document*
​
​​​​​​​​
101.PRE​Inline XBRL Taxonomy Extension Presentation Linkbase Document*
​​​​​​​​
104​Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)​​​​*
  • Filed herewith.

** Furnished herewith.

Annexes, schedules and exhibits have been omitted pursuant to Item 601(a)(5)(b)(2) of Regulation S-K. The Registrant hereby agrees to furnish supplementally a copy of any omitted annex, schedule or exhibit to the SEC upon request.

† Denotes a management contract or compensation plan or arrangement.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.